• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性乳糜微粒血症综合征患者血小板计数和血小板功能餐后波动的分析。

Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndrome.

机构信息

Department of Medicine, Université de Montréal, ECOGENE-21, 930 Jacques Cartier Est, Chicoutimi, G7H 7K9, Canada.

出版信息

Orphanet J Rare Dis. 2023 Jun 27;18(1):167. doi: 10.1186/s13023-023-02743-0.

DOI:10.1186/s13023-023-02743-0
PMID:37370069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10294360/
Abstract

BACKGROUND

The familial chylomicronemia syndrome (FCS) is an ultra rare disease caused by lipoprotein lipase (LPL) deficiency associated with potentially lethal acute pancreatitis risk. Thrombocytopenia (platelet count < 150,000 × 10/L) has been reported in patients with FCS, treated or not with volanesorsen, a second generation APOC3 anti-sense oligonucleotide. Chylomicrons are the lipoproteins delivering fat after a meal and FCS thus has a post-prandial origin. Platelet count and function have not been studied post-prandially in FCS.

OBJECTIVE

To evaluate post-prandial fluctuations in the platelet count (PLC) and functional defects of hemostasis in FCS.

METHODS

PLC, functional defects in hemostasis and hematologic variables were measured up-to 5 h after a meal in 6 homozygotes for FCS causing gene variants (HoLPL), 6 heterozygotes for LPL loss-of-function variants (HeLPL) and 7 normolipidemic controls.

RESULTS

Hourly post-prandial PLC was significantly lower in HoLPL than in controls (P < 0.009). Compared to the other groups, the PLC tended to decrease rapidly (in the first hour) post-meal in HoLPL (P = 0.03) and remained lower than baseline 5-h post-meal (P = 0.02) whereas it tended to slightly increase in normolipidemic controls (P = 0.02). Platelet function was not affected by the prandial status. In HoLPL, post-prandial fluctuations in the PLC positively correlated with the lymphocyte count (P = 0.005) and negatively with neutrophil/lymphocyte ratio (NLR).

CONCLUSION

The PLC decreases post-prandially in FCS (HoLPL), is not associated with changes in functional defects of hemostasis and correlates with the NLR, a marker of acute pancreatitis severity.

摘要

背景

家族性乳糜微粒血症综合征(FCS)是一种极为罕见的疾病,由脂蛋白脂肪酶(LPL)缺乏引起,与潜在致命的急性胰腺炎风险相关。已报道 FCS 患者存在血小板减少症(血小板计数 < 150,000 × 10/L),无论是否接受沃拉森瑟治疗,一种第二代 APOC3 反义寡核苷酸。乳糜微粒是餐后输送脂肪的脂蛋白,因此 FCS 具有餐后起源。尚未在 FCS 中研究餐后血小板计数(PLC)和止血功能缺陷。

目的

评估 FCS 餐后血小板计数(PLC)波动和止血功能缺陷。

方法

在 6 名 FCS 纯合子导致基因突变的患者(HoLPL)、6 名 LPL 功能丧失变异的杂合子患者(HeLPL)和 7 名血脂正常的对照者中,在餐后 5 小时内测量 PLC、止血功能缺陷和血液学变量。

结果

HoLPL 餐后每小时 PLC 明显低于对照组(P < 0.009)。与其他组相比,HoLPL 组餐后 PLC 迅速下降(第一小时)(P = 0.03),且在餐后 5 小时仍低于基线(P = 0.02),而血脂正常对照组则略有增加(P = 0.02)。血小板功能不受进餐状态的影响。在 HoLPL 中,PLC 餐后波动与淋巴细胞计数呈正相关(P = 0.005),与中性粒细胞/淋巴细胞比值(NLR)呈负相关。

结论

FCS(HoLPL)餐后 PLC 降低,与止血功能缺陷变化无关,与 NLR 相关,NLR 是急性胰腺炎严重程度的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65b/10294360/f602919a2313/13023_2023_2743_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65b/10294360/e032fdafbcff/13023_2023_2743_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65b/10294360/00677d860458/13023_2023_2743_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65b/10294360/f602919a2313/13023_2023_2743_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65b/10294360/e032fdafbcff/13023_2023_2743_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65b/10294360/00677d860458/13023_2023_2743_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65b/10294360/f602919a2313/13023_2023_2743_Fig3_HTML.jpg

相似文献

1
Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndrome.家族性乳糜微粒血症综合征患者血小板计数和血小板功能餐后波动的分析。
Orphanet J Rare Dis. 2023 Jun 27;18(1):167. doi: 10.1186/s13023-023-02743-0.
2
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.家族性乳糜微粒血症不同分子病因的临床和生化特征。
J Clin Lipidol. 2018 Jul-Aug;12(4):920-927.e4. doi: 10.1016/j.jacl.2018.03.093. Epub 2018 Apr 4.
3
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study.用volanesorsen治疗的家族性乳糜微粒血症综合征患者血小板聚集和凝血酶生成的评估:一项横断面研究。
Biomedicines. 2024 Sep 4;12(9):2017. doi: 10.3390/biomedicines12092017.
4
Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.甘油三酯相关基因的罕见变异增加多因素乳糜微粒血症综合征的胰腺炎风险。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3473-e3482. doi: 10.1210/clinem/dgab360.
5
Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity.乳糜微粒血症诊断评分与肝素后脂蛋白脂肪酶活性之间的相关性。
Clin Biochem. 2023 Apr;114:67-72. doi: 10.1016/j.clinbiochem.2023.02.002. Epub 2023 Feb 11.
6
Volanesorsen for treatment of familial chylomicronemia syndrome.用于治疗家族性乳糜微粒血症综合征的 Volanesorsen。
Expert Rev Cardiovasc Ther. 2021 Aug;19(8):685-693. doi: 10.1080/14779072.2021.1955348. Epub 2021 Jul 27.
7
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.伏拉瑞斯森与家族性乳糜微粒血症综合征中的甘油三酯水平
N Engl J Med. 2019 Aug 8;381(6):531-542. doi: 10.1056/NEJMoa1715944.
8
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial.伏拉瑞司森与家族性乳糜微粒血症综合征患者的甘油三酯水平:一项开放标签扩展试验中患者的长期疗效和安全性数据。
J Clin Lipidol. 2023 May-Jun;17(3):342-355. doi: 10.1016/j.jacl.2023.03.007. Epub 2023 Mar 22.
9
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.严重高甘油三酯血症和家族性乳糜微粒血症综合征的药物治疗选择。
Expert Rev Clin Pharmacol. 2018 Jun;11(6):589-598. doi: 10.1080/17512433.2018.1480368. Epub 2018 Jun 11.
10
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.家族性乳糜微粒血症综合征:内分泌科临床指南
Endocr Pract. 2018 Aug;24(8):756-763. doi: 10.4158/EP-2018-0157.

引用本文的文献

1
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study.用volanesorsen治疗的家族性乳糜微粒血症综合征患者血小板聚集和凝血酶生成的评估:一项横断面研究。
Biomedicines. 2024 Sep 4;12(9):2017. doi: 10.3390/biomedicines12092017.
2
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia.严重高甘油三酯血症中血管生成素样蛋白 3 或 3/8 复合物和载脂蛋白 C-III 的抑制作用。
Curr Atheroscler Rep. 2023 Dec;25(12):1101-1111. doi: 10.1007/s11883-023-01179-y. Epub 2023 Dec 14.

本文引用的文献

1
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.载脂蛋白 C-III 抑制剂 volanesorsen 治疗多病因乳糜微粒血症患者的疗效和安全性(COMPASS):一项多中心、双盲、随机、安慰剂对照、3 期临床试验。
Lancet Diabetes Endocrinol. 2021 May;9(5):264-275. doi: 10.1016/S2213-8587(21)00046-2. Epub 2021 Mar 30.
2
Antisense technology: A review.反义技术:综述。
J Biol Chem. 2021 Jan-Jun;296:100416. doi: 10.1016/j.jbc.2021.100416. Epub 2021 Feb 16.
3
Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates.
序列特异性 2'-O-甲氧基乙基反义寡核苷酸通过糖蛋白 VI 激活人血小板,引发血小板-白细胞聚集体的形成。
Haematologica. 2022 Feb 1;107(2):519-531. doi: 10.3324/haematol.2020.260059.
4
The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?下一代降低甘油三酯的药物:降低载脂蛋白 C-III 或血管生成素样蛋白 3 是否能降低心血管疾病风险?
Curr Opin Lipidol. 2020 Jun;31(3):140-146. doi: 10.1097/MOL.0000000000000679.
5
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.伏拉瑞斯森与家族性乳糜微粒血症综合征中的甘油三酯水平
N Engl J Med. 2019 Aug 8;381(6):531-542. doi: 10.1056/NEJMoa1715944.
6
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.描述家族性乳糜微粒血症综合征:APPROACH 研究的基线数据。
J Clin Lipidol. 2018 Sep-Oct;12(5):1234-1243.e5. doi: 10.1016/j.jacl.2018.05.013. Epub 2018 May 31.
7
Update on the laboratory investigation of dyslipidemias.血脂异常的实验室检查进展。
Clin Chim Acta. 2018 Apr;479:103-125. doi: 10.1016/j.cca.2018.01.015. Epub 2018 Jan 11.
8
Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis.中性粒细胞与淋巴细胞比值作为急性胰腺炎患者不良结局早期预测指标的临床意义
World J Gastroenterol. 2017 Jun 7;23(21):3883-3889. doi: 10.3748/wjg.v23.i21.3883.
9
The Effects of 2'-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials.含2'-O-甲氧基乙基反义寡核苷酸在人体临床试验中对血小板的影响。
Nucleic Acid Ther. 2017 Jun;27(3):121-129. doi: 10.1089/nat.2016.0650. Epub 2017 Feb 1.
10
Postprandial Hyperlipidemia and Remnant Lipoproteins.餐后高脂血症与残留脂蛋白
J Atheroscler Thromb. 2017 Feb 1;24(2):95-109. doi: 10.5551/jat.RV16003. Epub 2016 Nov 8.